Form 4 holding
Director
Viridian Therapeutics, Inc.\DE
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 21,000
- Estimated value
- Report date
- 01 Jul 2025
- Price
- Ownership
- Indirect
- Underlying class
- Common Stock
- Underlying amount